Overview

Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to test if etoricoxib decreases the perioperative blood loss compared to diclofenac. Secondary questions to be explored are: - Does etoricoxib prevent Heterotopic ossification after Total Hip Arthroplasty as well as diclofenac ? - Do diclofenac and etoricoxib both reduce pain at rest and on movements? - Does etoricoxib compared to diclofenac reduce the amount of rescue medication (Oxycodon)? - Does etoricoxib improve gastrointestinal tolerability compared to diclofenac?
Phase:
Phase 3
Details
Lead Sponsor:
University of Regensburg
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Diclofenac
Etoricoxib